| CEO Name | Pierre Boulud |
| Nationality | France |
| Net Worth Estimation | $5 million |
Pierre Boulud's estimated net worth of around $5 million is primarily attributed to his executive compensation, equity holdings, and performance-based incentives as CEO of bioMerieux SA. His financial profile reflects industry benchmarks for C-level executives in European biotechnology firms and disclosures in public company filings.
Pierre Boulud, CEO of Biomerieux SA, has an estimated net worth of $5,000,000, which is 5.6% of the healthcare business category's maximum CEO net worth estimate ($90,000,000). His net worth is also 50% below the minimum estimated net worth ($10,000,000) for CEOs in this sector.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Pierre Boulud Performance in Biomerieux SA
Pierre Boulud, CEO of bioMerieux SA, demonstrates decisive leadership focused on innovation and global market expansion in the in-vitro diagnostics industry. His strategic decisions have accelerated product development and digital transformation, enhancing operational efficiency and competitive positioning. Under Boulud's performance-driven approach, bioMerieux has strengthened its R&D pipeline and solidified its status as a leader in infectious disease diagnostics worldwide.
Latest News
bioMerieux Confirms Growth and Strategic Focus in 2025
The company reported strong organic sales growth in the first nine months of 2025, reaching EUR2.99 billion, with a 7.3% increase in organic sales, driven by its strategic GO*28 plan and innovations in diagnostics. Alexandre Merieux serves as Executive Chairman, while Pierre Boulud is the CEO, leading the company's governance and operational strategy.
Source: http://www.zonebourse.com/actualite-bourse/biomerieux-biomerieux-a-information-financiere-du-3eme-trimestre-2025-ce7d5cdfde81f426